AT 2 receptor-mediated vasodilation in the mouse heart depends on AT 1A receptor activation

British Journal of Pharmacology

Volumn 148, Issue 4, 2006, Pages 452-458

  Van Esch, Joep H M ^a   Schuijt, Martin P ^a   Sayed, Jilani ^a   Choudhry, Yawar ^a   Walther, Thomas ^a   Jan Danser, A H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin II; Coronary artery; Langendorff model; Mouse; Vasodilation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1A RECEPTOR; IRBESARTAN; N(G) NITROARGININE METHYL ESTER; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PHENYLEPHRINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DATA ANALYSIS; EVALUATION; HEART; HEART LEFT VENTRICLE CONTRACTION; HEART PERFUSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VASOCONSTRICTION; VASODILATATION; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG EFFECT; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; CORONARY CIRCULATION; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; VASODILATION;

EID: 33745094426     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706762     Document Type: Article

References (55)

1. ABDALLA, S., LOTHER, H., ABDEL-TAWAB, A.M. & QUITTERER, U. (2001). The angiotensin II AT2 receptor is an AT1 receptor antagonist. J. Biol. Chem., 276, 39721-39726.
2. ABDELLATIF, M.M., NEUBAUER, C.F., LEDERER, W.J. & ROGERS, T.B. (1991). Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor. Circ. Res., 69, 800-809.
3. BARBER, M.N., SAMPEY, D.B. & WIDDOP, R.E. (1999). AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension, 34, 1112-1116.
4. BATENBURG, W.W., GARRELDS, I.M., BERNASCONI, C.C., JUILLERAT-JEANNERET, L., VAN KATS, J.P., SAXENA, P.R. & DANSER, A.H.J. (2004). Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation, 109, 2296-2301.
5. BATENBURG, W.W., TOM, B., SCHUIJT, M.P. & DANSER, A.H.J. (2005). Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). Vasc. Pharmacol., 42, 109-118.
6. CASTRO, C.H., SANTOS, R.A., FERREIRA, A.J., BADER, M., ALENINA, N. & ALMEIDA, A.P. (2005). Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension, 46, 937-942.
7. CHEN, X., LI, W., YOSHIDA, H., TSUCHIDA, S., NISHIMURA, H., TAKEMOTO, F., OKUBO, S., FOGO, A., MATSUSAKA, T. & ICHIKAWA, I. (1997). Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am. J. Physiol., 272, F299-F304.
8. CURTIS, M.J., MACLEOD, B.A., TABRIZCHI, R. & WALKER, M.J. (1986). An improved perfusion apparatus for small animal hearts. J. Pharmacol. Methods, 15, 87-94.
9. DELEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
10. (+) (BK(Ca)) channels. Hypertension, 37, 301-307.
11. DUKE, L.M., EVANS, R.G. & WIDDOP, R.E. (2005). AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats. Am. J. Physiol. Heart Circ. Physiol., 288, H2289-H2297.
12. ELTON, T.S., STEPHAN, C.C., TAYLOR, G.R., KIMBALL, M.G., MARTIN, M.M., DURAND, J.N. & OPARIL, S. (1992). Isolation of two distinct type I angiotensin II receptor genes. Biochem. Biophys. Res. Commun., 184, 1067-1073.
13. ENDO, Y., ARIMA, S., YAOITA, H., TSUNODA, K., OMATA, K. & ITO, S. (1998). Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J. Vasc. Res., 35, 421-427.
14. GUSTAFSON, L.A. & VAN BEEK, J.H. (2000). Measurement of the activation time of oxidative phosphorylation in isolated mouse hearts. Am. J. Physiol. Heart Circ. Physiol., 279, H3118-H3123.
15. HANNAN, R.E., DAVIS, E.A. & WIDDOP, R.E. (2003). Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br. J. Pharmacol., 140, 987-995.
16. HARADA, K., KOMURO, I., SHIOJIMA, I., HAYASHI, D., KUDOH, S., MIZUNO, T., KIJIMA, K., MATSUBARA, H., SUGAYA, T., MURAKAMI, K. & YAZAKI, Y. (1998). Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation, 97, 1952-1959.
17. HEIN, L., BARSH, G.S., PRATT, R.E., DZAU, V.J. & KOBILKA, B.K. (1995). Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature, 377, 744-747.
18. ICHIHARA, S., SENBONMATSU, T., PRICE JR, E., ICHIKI, T., GAFFNEY, F.A. & INAGAMI, T. (2001). Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation, 104, 346-351.
19. ICHIKI, T., LABOSKY, P.A., SHIOTA, C., OKUYAMA, S., IMAGAWA, Y., FOGO, A., NIIMURA, F., ICHIKAWA, I., HOGAN, B.L. & INAGAMI, T. (1995). Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature, 377, 748-750.
20. i, inositol triphosphate and prolactin in pituitary cells. Am. J. Physiol. Endocrinol. Metab., 280, E462-E470.
21. ITO, M., OLIVERIO, M.I., MANNON, P.J., BEST, C.F., MAEDA, N., SMITHIES, O. & COFFMAN, T.M. (1995). Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. U.S.A., 92, 3521-3525.
22. IWAI, N. & INAGAMI, T. (1992). Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett., 298, 257-260.
23. JIN, X.Q., FUKUDA, N., SU, J.Z., LAI, Y.M., SUZUKI, R., TAHIRA, Y., TAKAGI, H., IKEDA, Y., KANMATSUSE, K. & MIYAZAKI, H. (2002). Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension, 39, 1021-1027.
24. KATADA, J. & MAJIMA, M. (2002). AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br. J. Pharmacol., 136, 484-491.
25. LEVY, B.I., BENESSIANO, J., HENRION, D., CAPUTO, L., HEYMES, C., DURIEZ, M., POITEVIN, P. & SAMUEL, J.L. (1996). Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest., 98, 418-425.
26. LI, X.C. & WIDDOP, R.E. (2004). AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br. J. Pharmacol., 142, 821-830.
27. MASAKI, H., KURIHARA, T., YAMAKI, A., INOMATA, N., NOZAWA, Y., MORI, Y., MURASAWA, S., KIZIMA, K., MARUYAMA, K., HORIUCHI, M., DZAU, V.J., TAKAHASHI, H., IWASAKA, T., INADA, M. & MATSUBARA, H. (1998). Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J. Clin. Invest., 101, 527-535.
28. MUKOYAMA, M., NAKAJIMA, M., HORIUCHI, M., SASAMURA, H., PRATT, R.E. & DZAU, V.J. (1993). Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem., 268, 24539-24542.
29. MULLER, C., ENDLICH, K. & HELWIG, J.J. (1998). AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature. Br. J. Pharmacol., 124, 946-952.
30. MUNZENMAIER, D.H. & GREENE, A.S. (1996). Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension, 27, 760-765.
31. NAKAJIMA, M., HUTCHINSON, H.G., FUJINAGA, M., HAYASHIDA, W., MORISHITA, R., ZHANG, L., HORIUCHI, M., PRATT, R.E. & DZAU, V.J. (1995). The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. U.S.A., 92, 10663-10667.
32. OLIVERIO, M.I., BEST, C.F., KIM, H.S., ARENDSHORST, W.J., SMITHIES, O. & COFFMAN, T.M. (1997). Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am. J. Physiol., 272, F515-F520.
33. PÖRSTI, I., HECKER, M., BASSENGE, E. & BUSSE, R. (1993). Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart. Naunyn Schmiedebergs Arch Pharmacol, 348, 650-658.
34. REAGAN, L.P., YE, X., MARETZSKI, C.H. & FLUHARTY, S.J. (1993). Down-regulation of angiotensin II receptor subtypes and desensitization of cyclic GMP production in neuroblastoma N1E-115 cells. J. Neurochem., 60, 24-31.
35. RYAN, M.J., DIDION, S.P., MATHUR, S., FARACI, F.M. & SIGMUND, C.D. (2004). Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice. Hypertension, 43, 1074-1079.
36. SCHNEIDER, M.D. & LORELL, B.H. (2001). AT(2), judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy? Circulation, 104, 247-248.
37. SCHUIJT, M.P., BASDEW, M., VAN VEGHEL, R., DE VRIES, R., SAXENA, P.R., SCHOEMAKER, R.G. & DANSER, A.H.J. (2001). AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. Am. J. Physiol. Heart Circ. Physiol., 281, H2590-H2596.
38. SCHUIJT, M.P., DE VRIES, R., SAXENA, P.R., SCHALEKAMP, M.A.D.H. & DANSER, A.H.J. (2002). Vasoconstriction is determined by interstitial rather than circulating angiotensin II. Br. J. Pharmacol., 135, 275-283.
39. SIRAGY, H.M. & CAREY, R.M. (1997). The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest., 100, 264-269.
40. SIRAGY, H.M., INAGAMI, T., ICHIKI, T. & CAREY, R.M. (1999). Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc. Natl. Acad. Sci. U.S.A., 96, 6506-6510.
41. STOLL, M., STECKELINGS, U.M., PAUL, M., BOTTARI, S.P., METZGER, R. & UNGER, T. (1995). The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest., 95, 651-657.
42. SUTHERLAND, F.J., SHATTOCK, M.J., BAKER, K.E. & HEARSE, D.J. (2003). Mouse isolated perfused heart: characteristics and cautions. Clin. Exp. Pharmacol. Physiol., 30, 867-878.
43. TANAKA, M., TSUCHIDA, S., IMAI, T., FUJII, N., MIYAZAKI, H., ICHIKI, T., NARUSE, M. & INAGAMI, T. (1999). Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem. Biophys. Res. Commun., 258, 194-198.
44. TOM, B., GARRELDS, I.M., SCALBERT, E., STEGMANN, A.P., BOOMSMA, F., SAXENA, P.R. & DANSER, A.H.J. (2003). ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency? Arterioscler. Thromb. Vasc. Biol., 23, 251-256.
45. TSUTSUMI, Y., MATSUBARA, H., MASAKI, H., KURIHARA, H., MURASAWA, S., TAKAI, S., MIYAZAKI, M., NOZAWA, Y., OZONO, R., NAKAGAWA, K., MIWA, T., KAWADA, N., MORI, Y., SHIBASAKI, Y., TANAKA, Y., FUJIYAMA, S., KOYAMA, Y., FUJIYAMA, A., TAKAHASHI, H. & IWASAKA, T. (1999). Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest., 104, 925-935.
46. UTSUNOMIYA, H., NAKAMURA, M., KAKUDO, K., INAGAMI, T. & TAMURA, M. (2005). Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice. Regul Pept, 126, 155-161.
47. VAN KATS, J.P., DANSER, A.H.J., VAN MEEGEN, J.R., SASSEN, L.M.A., VERDOUW, P.D. & SCHALEKAMP, M.A.D.H. (1998). Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation, 98, 73-81.
48. VAN KESTEREN, C.A.M., VAN HEUGTEN, H.A.A., LAMERS, J.M.J., SAXENA, P.R., SCHALEKAMP, M.A.D.H. & DANSER, A.H.J. (1997). Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J. Mol. Cell Cardiol., 29, 2147-2157.
49. WANG, Q.D., TOKUNO, S., VALEN, G., SJOQUIST, P.O. & THOREN, P. (2002). Cyclic fluctuations in the cardiac performance of the isolated Langendorff-perfused mouse heart: pyruvate abolishes the fluctuations and has an anti-ischaemic effect. Acta Physiol. Scand., 175, 279-287.
50. WIDDOP, R.E., JONES, E.S., HANNAN, R.E. & GASPARI, T.A. (2003). Angiotensin AT2 receptors: cardiovascular hope or hype? Br. J. Pharmacol., 140, 809-824.
51. WIDDOP, R.E., MATROUGUI, K., LEVY, B.I. & HENRION, D. (2002). AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension, 40, 516-520.
52. YANG, Z., BOVE, C.M., FRENCH, B.A., EPSTEIN, F.H., BERR, S.S., DIMARIA, J.M., GIBSON, J.J., CAREY, R.M. & KRAMER, C.M. (2002). Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation, 106, 106-111.
53. YEE, D.K., HEERDING, J.N., KRICHAVSKY, M.Z. & FLUHARTY, S.J. (1998). Role of the amino terminus in ligand binding for the angiotensin II type 2 receptor. Brain Res. Mol. Brain Res., 57, 325-329.
54. YOU, D., LOUFRANI, L., BARON, C., LEVY, B.I., WIDDOP, R.E. & HENRION, D. (2005). High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation, 111, 1006-1011.
55. ZHANG, C., HEIN, T.W., WANG, W. & KUO, L. (2003). Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ. Res., 92, 322-329.